The present technology is generally related to intramedullary nail implantation for treatment of bone fractures. In particular, several embodiments are directed to systems and methods for implanting an intramedullary nail for immobilizing bone fractures.
The significant long bones of the extremities are the humerus, radius and ulna of the upper extremity and the femur and tibia of the lower extremity. Following an injury to the long bone, and in particular, injuries resulting in one or more fractures of the long bone, one or more fixation devices may be used to immobilize the fracture fragments and stabilize the long bone. Bone fractures can be treated with screws or other fixation devices inserted into or through the bone to stabilize it once the fractured portions have been brought into proper alignment. Femoral neck fixation, for example, can be used to treat hip fractures by inserting an intramedullary nail into the medullary cavity of the fractured femur followed by insertion of a fixation screw into the femoral neck/head at an angle relative to the intramedullary nail. Similarly, other long bone fractures can be treated by inserting an intramedullary nail into the intramedullary canal of the bone and providing the appropriate proximal and/or distal fixation. Traditional intramedullary devices may suffer from a number of disadvantages, however. For example, they may be susceptible to implant failure and difficulty in alignment of the fixation screw with respect to the intramedullary nail. Accordingly, there is a need for improved systems and methods for intramedullary nail implantation.
Intramedullary nails, systems, insertion tools, and method of treatment are provided. The intramedullary nails may be suitable for implanting within a medullary canal of a fractured long bone and subsequently providing proximal fixation and/or distal fixation, for example, with one or more anchors, fasteners, fixation screws, or the like. Suitable long bones may include the humerus, radius, ulna, femur, tibia, or the like. Although generally described with reference to the femur, it will be appreciated that the intramedullary nail and system may be adapted for use with any long bone.
According to one aspect, an intramedullary nail is provided. The intramedullary nail may comprise a generally elongate body extending from a first, distal end to a second, proximal end. The distal end may include one or more openings configured to receive one or more bone anchors or fasteners that extend transversely through the distal end intramedullary nail, and thereby configured to secure the distal end of the nail. The proximal end may also include one or more openings configured to receive one or more bone anchors or fasteners that extend transversely through the proximal end of the intramedullary nail, and thereby configured to secure the proximal end of the nail.
In one aspect, a system for inserting an intramedullary nail into a bone is provided. The system includes an intramedullary nail with an opening or aperture formed therein. An insertion tool includes can temporarily engage with an end of the intramedullary nail during implantation, and release from the nail once the procedure is complete. A receiving feature for a guide sheath (e.g., a hole, recess, etc.) is disposed in the handle portion and can receive a guide sheath therethrough. The receiving feature defines an axis such that, when the intramedullary nail is coupled to the coupling portion, a guide sheath inserted through the receiving feature substantially aligns with the aperture in the intramedullary nail. A first retention member is disposed in the insertion tool adjacent to the guide sheath receiving feature. The first retention member can interact with a second retention member on the guide sheath to form a ratchet-like mechanism that restrict movement of the guide sheath with respect to the receiving feature. A retention release mechanism can be located on a lower portion (e.g., a bottom surface) of the insertion tool. A guide wire receptacle (e.g., a hole, recess, etc.) can receives a guide wire therethrough and is positioned such that, when the intramedullary nail is coupled to the coupling portion, a guide wire inserted through the receiving feature runs along an axis adjacent to the side surface of the intramedullary nail.
In another aspect, a method for inserting an intramedullary nail into a patient is provided. The method includes inserting a nail into a medullary canal of a patient along a first axis. For insertion, the nail is coupled at its proximal end to an insertion tool. A guide wire is inserted through a guide wire hole in the insertion tool along a second axis such that the guide wire runs nearby or adjacent to a side surface of the nail. A screw or other bone fixation device is inserted through receptacle (e.g., a hole, recess, or other suitable structure) formed in the insertion tool such that the screw passes through an aperture formed in the nail.
In accordance with another aspect, an implant is provided. The implant includes an intramedullary nail that is elongated along a first axis. First and second openings or apertures are disposed in a proximal portion of the nail. The first aperture defines a second axis transverse to the first axis, and the second aperture defines a third axis transverse to the first axis. The third axis intersects with the second axis at a point spaced apart from the nail. In some embodiments, the first screw can be inserted through the first aperture along the second axis and a second screw can be inserted through the second aperture along the third axis. The second screw can be at least partially inserted through a slot in the first screw such that the two screws interlock. The second screw can be shorter than the first screw but long enough that at least a threaded distal tip extends beyond the slot in the first screw to provide some purchase in the bone.
In accordance with another embodiment, an implant includes an intramedullary nail, a first fixation device, and a second fixation device. The intramedullary nail has an elongate body extending from a proximal portion to a distal portion where a portion of the elongate body extends along a first axis. A first aperture is formed in the proximal portion. The first aperture defines a second axis transverse to the first axis. A second aperture is formed in the proximal portion. The second aperture is spaced apart from the first aperture. The second aperture defines a third axis transverse to the first axis. The third axis intersects with the second axis at a point spaced apart from the body. The first fixation device is positionable through the first aperture in the nail. The first fixation device has an elongate slot extending therethrough. The second fixation device is positionable through the second aperture in the nail, and the second fixation device is positionable through the elongate slot in the first fixation device.
Also provided are kits including intramedullary nails of varying shapes and sizes, bone anchors, fasteners, insertion tools, and components for installing the same.
A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
Intramedullary nails, systems, insertion tools, and method of treatment are provided. The intramedullary nails may be suitable for implantation within the intramedullary canal of a fractured long bone and subsequently providing proximal fixation and/or distal fixation, for example, with one or more anchors, fasteners, fixation screws, or the like. Suitable long bones may include the humerus, radius, ulna, femur, tibia, or the like. Although further described with reference to hip fractures of the femur, it will be appreciated that the intramedullary nail and system may be adapted for use with any long bone.
In conventional hip fracture fixation techniques, there are four main failure modes: axial cutout, cephalad cutout, proximal fragment rotation, and nonunion. “Cutout” is the term for hip screw subsidence into the articular surface of the hip. Cutout can occur in either a cephalad (toward the head) or axial direction (along the axis of the hip screw). Axial cutout is the result of an implant with a small axial profile that provides little resistance to axial translation. Axial cutout can be addressed by the “controlled collapse” features on certain modern hip fracture nails; the hip screw is allowed to translate through the nail, even after the set screw is locked in place. Cephalad cutout is the radial translation of the nail which is the result of a narrow implant that “windshield wipers” through the weak cancellous bone in the hip. Proximal fragment rotation is the result of a circular profile hip screw that acts as a fulcrum to the proximal hip fragment. Fracture nonunion is the result of biologic or mechanical factors that are incompatible with the bone healing process. Biologic factors of the patient are not controllable by the implant. Mechanical factors are those that typically allow fixation that is too rigid or too flexible. Nonunion is usually the precursor to one of the other three failure modes. Occasionally, nonunion will cause the nail to break in fatigue before the bone fails.
The intramedullary nails and systems described herein may address one or more of these failure modes. In some embodiment, the intramedullary nail includes proximal and distal locking, for example, to prevent cutout. In other embodiments, the intramedullary nail may include proximal locking including two interlocking fixation devices (e.g., screws), for example, by providing converging and diverging purchase, along with bony fixation in the calcar of the femur, which is the strongest portion of the hip bone. Accordingly, the risk of failure due to cutout and/or rotation can be reduced.
Additionally, some intramedullary nail implantation systems fail to adequately address the problems of fragment rotation during implantation. Rotation occurs when fragments of the bone rotate about the axis of the screw during the implantation procedure. Conventional anti-rotation technologies require the use of additional instruments or are limited to a single wire placement. In some embodiments, an insertion tool is directly coupled to the intramedullary nail and additional instruments are not needed for the placement of an anti-rotation guide wire and allow the user to place one or more guide wires anterior and/or posterior to the nail. These guide wires can be positioned to prevent the distal fragments of the femoral head and neck from rotating about the axis of the anchor during the procedure.
Some systems may be susceptible to backout during the implantation procedure. Backout occurs when the guide sheath used to insert the screw through the intramedullary nail moves proximally away from the bone. Conventional systems either have no features to prevent backout or else provide backout prevention measures that obstruct the normal positioning of the hands during the procedure, resulting in the risk of releasing the guide sheaths and dropping them to the floor. Ratchets on the insertion tool may have the release button facing towards the grip portion on the insertion tool and may present the danger of the user's hand slipping and inadvertently pressing the button. Accidentally pressing the button could result in releasing the sheath and causing the sheath to fall on the floor. In some embodiments, a backout prevention system (e.g., a ratchet system) may be disposed on the lower end of the insertion tool, which allows a user to have a hand placed on the grip of the insertion tool without the risk of inadvertently pressing the ratchet release button.
Further specific details of several embodiments of the present technology are described below with reference to
For ease of reference, throughout this disclosure identical reference numbers are used to identify similar or analogous components or features, but the use of the same reference number does not imply that the parts should be construed to be identical. Indeed, in many examples described herein, the identically numbered parts are distinct in structure and/or function.
Intramedullary Nail Implants and Systems
The distal end 110 may include one or more openings 125 configured to receive one or more bone anchors, fasteners, or distal fixation devices 147 that extend transversely through the distal end 110 of the intramedullary nail 109, and are thereby configured to secure the distal end 110 of the nail 109 within the canal. The distal fixation devices 147 may include a bone screw or anchor configured for distal locking of the nail 109. The distal fixation device 147 may include traditional polyaxial or fixed angle locking bone screws and anchors known in the art.
The proximal end 111 may also include one or more openings 123 configured to receive one or more bone anchors or fasteners 119 that extend transversely through the proximal end 111 of the intramedullary nail 109, and are thereby configured to secure the proximal end 111 of the nail 109 within the canal. The proximal fixation devices 119 may include a bone screw or anchor configured for proximal locking of the nail 109. The fixation device 119 may be a calcar screw or anchor configured to be aimed at a calcar region of the proximal femur, which may constitute the best quality bone in the region. The opening 123 and anchor 119 may be angled, for example, about 100-150°, 110-140°, or about 120-135° relative to the nail 119 to engage the calcar region of the bone. The calcar screw 119 may have an enlarged diameter relative to the distal screw 147. The proximal fixation device 119 may include traditional polyaxial or fixed angle calcar screws and anchors known in the art. The proximal end 111 may also include additional openings 123, for example, for one or more cross-locking devices (e.g., device 205 described in more detail below).
The intramedullary nail 109 and anchors 119, 147 may be comprised of any suitable biocompatible materials. The intramedullary nail 109 and anchors 119, 147 may be comprised of titanium, cobalt chrome, cobalt-chrome-molybdenum, stainless steel, tungsten carbide, carbon composite, plastic or polymer—such as polyetheretherketone (PEEK), polyethylene, ultra high molecular weight polyethylene (UHMWPE), resorbable polylactic acid (PLA), polyglycolic acid (PGA), combinations or alloys of such materials, or other appropriate biocompatible materials that have sufficient strength to secure and hold bone, while also having sufficient biocompatibility to be implanted into a body.
System for Intramedullary Nail Implantation
The handle portion 107 may include one or more openings 127, 129 configured to receive one or more guide wires 113, 115. In one embodiment, the system 101 may include first and second guide wires 113, 115 as well as an optional guide sheath 117 through which the fixation device 119 may pass (e.g., the fixation device 119 can be inserted using the driver 121). As illustrated, the first and second guide wires 113, 115 may pass on opposing sides of both the nail 109 and the fixation device 119 (e.g. on posterior and anterior sides). Although the illustrated embodiment shows two guide wires, in other embodiments a single guide wire and corresponding guide wire hole may be used. In still other embodiments, three or more guide wires may be used. Additionally, the position and orientation of the guide wire holes can vary in different embodiments, for example being disposed more proximally or more distally along the insertion tool, etc.
As illustrated, the insertion tool 103 allows the user to place one or more guide wires 113, 115. In one embodiment, the guide wires 113, 155 are positioned both anterior and posterior to the nail 109. The guide wires 113, 115 may be positioned in this manner to prevent the distal fragments of the bone (e.g., distal fragments of the femoral head and neck) from rotating about the axis of the fixation device 119 when the fixation device 119 is advanced through the nail 109 and into the bone during the procedure. The handle portion 107 of the insertion tool 103 may include two guide wire receiving features such as holes 127, 129 on the opposing sides of the tool 103 that allow guide wires 113, 115 to pass through the respective holes. The guide wires 113, 115 are passed through the soft tissue and into the bone to help stabilize the insertion tool 103. In this configuration, the insertion tool 103 may not require any other instruments to guide the wires 113, 115 into the patient. The insertion tool 103 can achieve stability by resisting both rotational movement about the axis of the nail 109 as well as axial translation along the axis of the nail 109.
The guide sheath 117 can be removably inserted through a guide sheath receiving feature such as a hole 131 formed in the handle portion 107 of the insertion tool 103. The guide sheath hole 131 defines an axis that intersects with a first aperture 123 in the nail 109. The guide sheath 117 can be positioned through the guide sheath hole 131 such that it substantially aligns with the first aperture 123 in the nail 109, which is configured to receive fixation device 119 aimed at the calcar region of the bone. The guide sheath 117 can include a first retention member 133 on an outer surface of the guide sheath 117. The first retention member 133 can include, for example, ridged teeth, protrusions, or other such surface configured to engage with a corresponding second retention member 135 disposed within the guide sheath hole 131. The second retention member 135 can likewise include one or more ridges or protrusions. Together the first and second retention members 133, 135 form a retention mechanism 137 that allows the guide sheath 117 to be ratcheted towards the intramedullary nail 109 while restricting movement of the guide sheath 117 away from the intramedullary nail. The retention release mechanism 139 can disengage the second retention member 135 from the first retention member 133 when pressed by a user. For example, the retention release mechanism 139 can be a button disposed on a lower surface 141 of the handle portion 107. Positioning this retention release mechanism 139 on the lower surface 141 of the insertion handle may prevent a user from accidentally releasing the guide sheath 117 while operating the device (e.g., while grasping the handle portion 107).
Interlocking Fixation Devices for Intramedullary Nail Fixation
Referring to
The first fixation device 203, may be the same or similar to the proximal fixation device 119, described herein, and may include a bone screw or anchor configured for proximal locking of the nail 201. For example, the first fixation device 203 may be a hip screw or anchor configured to be aimed at a head region of the proximal femur. The anchor 203 may have a threaded portion at its distal tip and a non-threaded portion along a substantial length of the screw 203. The anchor 203 may include traditional polyaxial or fixed angle screws and anchors known in the art.
The second fixation device 205 may also include a bone screw or anchor configured for proximal locking of the nail 201. This bone anchor or screw 205 may be substantially smaller in length and diameter relative to the calcar screw 203. The bone anchor or screw 205 is substantially sized and configured to be positioned through second opening 211 in the proximal end of the nail 201 and into a channel 219 in the first fixation device 203. Thus, the second device 205 is configured to interlock with the first fixation device 203, for example, for enhanced purchase and bony fixation to the bone. The second fixation device 205 may be positioned to engage at or near the calcar region of bone. Although shown with the second fixation device 205 positioned above the first fixation device 203 and angled downwardly into contact with the first fixation device 203, it is also envisioned that these relative positons may be reversed or the fixation devices 203, 205 may otherwise be angled with respect to one another in order to interlock the devices 203, 205 with one another. The second fixation device 205 may be configured to pass through a slot or channel 219 formed in the first fixation device 203. This interlocking feature of the first and second fixation devices 203, 205 can prevent cutout and rotation by providing converging and diverging purchase. In the case of a femur, this can also provide bony fixation in the calcar. The elongated slot 219 in the first fixation device 203 allows for controlled collapse, which leverages the natural compression between fragments from weight bearing or ligamentotaxis. Limited collapse is controlled by the length of the slot 219 to prevent the uncontrolled and excessive shortening of the femoral neck. The first fixation device 203 may include distal threads 221 and a proximal drive interface 223 configured to engage with a driver (not shown). The second fixation device 205 may have a narrower diameter than the first fixation device 203 such that the second fixation device 205 can pass through the slot 219 in the first fixation device 203. The second fixation device 205 may also include distal threads 225 and a proximal drive interface 227 configured to engage with a driver (not shown).
The slot 219 can be disposed in the mid-shaft of the first fixation device 203 and may be sized and configured to allow the second fixation device 205 to pass therethrough. The slot 219 may be longer than necessary to allow translation of the first fixation device 203 after the second fixation device 205 is in place. The slot 219 may be strong enough to prevent rotation of the first fixation device 203 after the second fixation device 205 is in position. The slot 219 may have beveled proximal and distal edges to maximize material in the first fixation device 203 while allowing proximal and distal clearance of the second fixation device 205. The slot 219, in the first fixation device 203, may be symmetric to allow positioning of the second fixation device 205 in 180° increments, for example.
In at least one embodiment, a locking device 230, such as a set screw or washer, may be used to lock the first and/or the second fixation devices 203, 205 into position. As best seen in
An insertion tool 103 for implanting the system including the nail 201 and the interlocking first and second fixation devices 203 and 205 can be substantially similar to the system 101 described above with respect to
Turning now to
With reference to
The first fixation device 303 includes an elongate opening, slot, or channel 319 extending therethrough. The channel 319 may be disposed in the mid-shaft of the first fixation device 303, for example, along the non-threaded portion. As best seen in
The second fixation device 205 is configured to interlock with the first fixation device 303. The second fixation device 205 is sized and configured to be positioned through the second opening 211 in the proximal end of the nail 201 and into the channel 319 in the first fixation device 303. The second fixation device 205 is configured to pass through the slot or channel 319 formed in the first fixation device 303 to provide for an interlocking feature of the first and second fixation devices 303, 205. The elongated slot 319 in the first fixation device 303 may provide for controlled or limited collapse of the first and second fixation devices 303, 2015, which may be controlled by the length of the slot 319.
The second fixation device 205 may be positioned at an angle α relative to the intramedullary nail 201. The angle α may extend between a longitudinal axis of the intramedullary nail 201 and a longitudinal axis of the second fixation device 205. The angle α may range from about 0-130°, about 0-90°, about 70-90°, or about 80-90°. The opening or aperture 211 in the intramedullary nail 201 may be angled, beveled, or provided with enough clearance to allow for variable angles of angle α. As shown in the side view and cross-sectional views of
The second fixation device 205 is also positioned at an angle β relative to the first fixation device 303. The angle β may extend between a longitudinal axis of the first fixation device 303 and a longitudinal axis of the second fixation device 205 relative to their distal most tips. The angle β may range from about 0-120°, about 0-90°, about 0-65°, about 0-45°, or about 25-65°. The opening or aperture 209 in the intramedullary nail 201 may be angled, beveled, or provided with enough clearance to allow for variable angles of angle β.
The channel or slot 319 may be sized substantially larger than an outer diameter of the second fixation device 205, for example, more than double, triple, or quadruple the outer diameter of the second fixation device 205. The enlarged slot 319 is sized to allow the second fixation device 205 to pass therethrough and translate along the length of the slot 319. The elongated slot 319 may allow for translation of the first fixation device 303 and/or the second fixation device 205 after the first and second fixation devices 303, 205 are implanted in bone. After implantation, the second fixation device 205 may reside within the slot 319 without contacting either of the proximal or distal ends 325, 327. The second fixation device 205 may be permitted to translate in the slot 319 until the second fixation device 205 contacts one of the first proximal or distal ends 325, 327, for example, one of the angled portions of the end 325, 327.
The cross-locking system 300 may address one or more of the major failure modes for hip fixation: axial cutout, cephalad cutout, fragment rotation, and nonunion. For example, the intersecting first and second fixation devices 303, 205 may provide for enhanced purchase in the head and neck region of the elongate bone. The overall system 300 can provide for improved stability and protection against common modes of implant failure.
Conclusion
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.
From the foregoing, it will be appreciated that specific embodiments of the invention have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
This application is a continuation of U.S. patent application Ser. No. 16/580,174, filed on Sep. 24, 2019 (published as U.S. Pat. Pub. No. 2020-0015875), which is a continuation of U.S. patent application Ser. No. 15/636,806, filed on Jun. 29, 2017 (now U.S. Pat. No. 10,463,416), which is a continuation-in-part of U.S. patent application Ser. No. 15/272,850, filed Sep. 22, 2016 (now U.S. Pat. No. 10,299,847), all of which are incorporated by reference herein in their entireties for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1105105 | Sherman | Jul 1914 | A |
2486303 | Longfellow | Oct 1949 | A |
3463148 | Treace | Aug 1969 | A |
3695259 | Yost | Oct 1972 | A |
3716050 | Johnston | Feb 1973 | A |
4219015 | Steinemann | Aug 1980 | A |
4493317 | Klaue | Jan 1985 | A |
4524765 | de Zbikowski | Jun 1985 | A |
4651724 | Berentey et al. | Mar 1987 | A |
4683878 | Carter | Aug 1987 | A |
4781183 | Casey et al. | Nov 1988 | A |
4867144 | Karas et al. | Sep 1989 | A |
4923471 | Morgan | May 1990 | A |
4966599 | Pollock | Oct 1990 | A |
4978349 | Frigg | Dec 1990 | A |
5002544 | Klaue et al. | Mar 1991 | A |
5034013 | Kyle et al. | Jul 1991 | A |
5041114 | Chapman et al. | Aug 1991 | A |
5151103 | Tepic et al. | Sep 1992 | A |
5259398 | Vrespa | Nov 1993 | A |
5354300 | Goble et al. | Oct 1994 | A |
5364399 | Lowery et al. | Nov 1994 | A |
5372598 | Luhr et al. | Dec 1994 | A |
5423826 | Coates et al. | Jun 1995 | A |
5429640 | Shuler | Jul 1995 | A |
5468242 | Reisberg | Nov 1995 | A |
D365634 | Morgan | Dec 1995 | S |
5489305 | Morgan | Feb 1996 | A |
5527311 | Procter et al. | Jun 1996 | A |
5578036 | Stone et al. | Nov 1996 | A |
5601553 | Trebing et al. | Feb 1997 | A |
5676667 | Hausman | Oct 1997 | A |
5690631 | Duncan et al. | Nov 1997 | A |
5709686 | Talos et al. | Jan 1998 | A |
5709687 | Pennig | Jan 1998 | A |
5718704 | Medoff | Feb 1998 | A |
5718705 | Sammarco | Feb 1998 | A |
5741256 | Bresina | Apr 1998 | A |
5746742 | Runciman et al. | May 1998 | A |
5766175 | Martinotti | Jun 1998 | A |
5766176 | Duncan | Jun 1998 | A |
5779706 | Tschakaloff | Jul 1998 | A |
5785712 | Runciman et al. | Jul 1998 | A |
5797914 | Leibinger | Aug 1998 | A |
5814048 | Morgan | Sep 1998 | A |
5925048 | Ahmad et al. | Jul 1999 | A |
5938664 | Winquist et al. | Aug 1999 | A |
5961519 | Bruce et al. | Oct 1999 | A |
5980540 | Bruce | Nov 1999 | A |
6001099 | Huebner | Dec 1999 | A |
6071291 | Forst et al. | Jun 2000 | A |
6093201 | Cooper et al. | Jul 2000 | A |
6096040 | Esser | Aug 2000 | A |
6107718 | Schustek et al. | Aug 2000 | A |
6152927 | Farris et al. | Nov 2000 | A |
6206881 | Frigg et al. | Mar 2001 | B1 |
6221074 | Cole | Apr 2001 | B1 |
6283969 | Grusin et al. | Sep 2001 | B1 |
6309393 | Tepic et al. | Oct 2001 | B1 |
6322562 | Wolter | Nov 2001 | B1 |
6364882 | Orbay | Apr 2002 | B1 |
D458683 | Bryant et al. | Jun 2002 | S |
D458684 | Bryant et al. | Jun 2002 | S |
6514253 | Yao | Feb 2003 | B1 |
6533786 | Needham et al. | Mar 2003 | B1 |
D479331 | Pike et al. | Sep 2003 | S |
6623486 | Weaver et al. | Sep 2003 | B1 |
6669700 | Farris et al. | Dec 2003 | B1 |
6669701 | Steiner et al. | Dec 2003 | B2 |
6712820 | Orbay | Mar 2004 | B2 |
6719759 | Wagner et al. | Apr 2004 | B2 |
6730091 | Pfefferle et al. | May 2004 | B1 |
6866665 | Orbay | Mar 2005 | B2 |
6955677 | Dahners | Oct 2005 | B2 |
6974461 | Wolter | Dec 2005 | B1 |
7001387 | Farris et al. | Feb 2006 | B2 |
7001388 | Orbay | Feb 2006 | B2 |
7063701 | Michelson | Jun 2006 | B2 |
7090676 | Huebner et al. | Aug 2006 | B2 |
7128744 | Weaver et al. | Oct 2006 | B2 |
7137987 | Patterson et al. | Nov 2006 | B2 |
7153309 | Huebner et al. | Dec 2006 | B2 |
7179260 | Gerlach et al. | Feb 2007 | B2 |
7250053 | Orbay | Jul 2007 | B2 |
7294130 | Orbay | Nov 2007 | B2 |
7322983 | Harris | Jan 2008 | B2 |
7341589 | Weaver et al. | Mar 2008 | B2 |
7344538 | Myerson et al. | Mar 2008 | B2 |
7354441 | Frigg | Apr 2008 | B2 |
7604657 | Orbay et al. | Oct 2009 | B2 |
7632277 | Woll et al. | Dec 2009 | B2 |
7635381 | Orbay | Dec 2009 | B2 |
7637928 | Fernandez | Dec 2009 | B2 |
7655029 | Niedernberger et al. | Feb 2010 | B2 |
7655047 | Swords | Feb 2010 | B2 |
7695472 | Young | Apr 2010 | B2 |
7717946 | Oepen et al. | May 2010 | B2 |
7722653 | Young et al. | May 2010 | B2 |
7740648 | Young et al. | Jun 2010 | B2 |
D622853 | Raven, III | Aug 2010 | S |
7771457 | Kay et al. | Aug 2010 | B2 |
7776076 | Grady, Jr. et al. | Aug 2010 | B2 |
7857838 | Orbay | Dec 2010 | B2 |
7867260 | Meyer et al. | Jan 2011 | B2 |
7867261 | Sixto, Jr. et al. | Jan 2011 | B2 |
7875062 | Lindemann et al. | Jan 2011 | B2 |
7905910 | Gerlach et al. | Mar 2011 | B2 |
7909858 | Gerlach et al. | Mar 2011 | B2 |
7918853 | Watanabe | Apr 2011 | B2 |
7951178 | Jensen | May 2011 | B2 |
7951179 | Matityahu | May 2011 | B2 |
7976570 | Wagner et al. | Jul 2011 | B2 |
D643121 | Millford et al. | Aug 2011 | S |
D646785 | Milford | Oct 2011 | S |
8043297 | Grady, Jr. et al. | Oct 2011 | B2 |
8057520 | Ducharme et al. | Nov 2011 | B2 |
8062296 | Orbay et al. | Nov 2011 | B2 |
8100953 | White et al. | Jan 2012 | B2 |
8105367 | Austin et al. | Jan 2012 | B2 |
8114081 | Kohut et al. | Feb 2012 | B2 |
8118846 | Leither et al. | Feb 2012 | B2 |
8118848 | Ducharme et al. | Feb 2012 | B2 |
8162950 | Digeser et al. | Apr 2012 | B2 |
8167918 | Strnad et al. | May 2012 | B2 |
8177820 | Anapliotis et al. | May 2012 | B2 |
8246661 | Beutter et al. | Aug 2012 | B2 |
8252032 | White et al. | Aug 2012 | B2 |
8257403 | Den Hartog et al. | Sep 2012 | B2 |
8257405 | Haidukewych et al. | Sep 2012 | B2 |
8257406 | Kay et al. | Sep 2012 | B2 |
8262707 | Huebner et al. | Sep 2012 | B2 |
8267972 | Gehlert | Sep 2012 | B1 |
8317842 | Graham et al. | Nov 2012 | B2 |
8323321 | Gradl | Dec 2012 | B2 |
8337535 | White et al. | Dec 2012 | B2 |
8343155 | Fisher et al. | Jan 2013 | B2 |
8382807 | Austin et al. | Feb 2013 | B2 |
8394098 | Orbay et al. | Mar 2013 | B2 |
8394130 | Orbay et al. | Mar 2013 | B2 |
8398685 | McGarity et al. | Mar 2013 | B2 |
8403966 | Ralph et al. | Mar 2013 | B2 |
8419775 | Orbay et al. | Apr 2013 | B2 |
8435272 | Dougherty et al. | May 2013 | B2 |
8439918 | Gelfand | May 2013 | B2 |
8444679 | Ralph et al. | May 2013 | B2 |
8491593 | Prien et al. | Jul 2013 | B2 |
8506608 | Cerynik et al. | Aug 2013 | B2 |
8512384 | Beutter et al. | Aug 2013 | B2 |
8512385 | White et al. | Aug 2013 | B2 |
8518090 | Huebner et al. | Aug 2013 | B2 |
8523862 | Murashko, Jr. | Sep 2013 | B2 |
8523919 | Huebner et al. | Sep 2013 | B2 |
8523921 | Horan et al. | Sep 2013 | B2 |
8540755 | Whitmore | Sep 2013 | B2 |
8551095 | Fritzinger et al. | Oct 2013 | B2 |
8551143 | Norris et al. | Oct 2013 | B2 |
8568462 | Sixto, Jr. et al. | Oct 2013 | B2 |
8574268 | Chan et al. | Nov 2013 | B2 |
8591513 | Overes | Nov 2013 | B2 |
8597334 | Mocanu | Dec 2013 | B2 |
8603147 | Sixto, Jr. et al. | Dec 2013 | B2 |
8617224 | Kozak et al. | Dec 2013 | B2 |
8632574 | Kortenbach et al. | Jan 2014 | B2 |
8641741 | Murashko, Jr. | Feb 2014 | B2 |
8641744 | Weaver et al. | Feb 2014 | B2 |
8663224 | Overes et al. | Mar 2014 | B2 |
8728082 | Fritzinger et al. | May 2014 | B2 |
8728126 | Steffen | May 2014 | B2 |
8740905 | Price et al. | Jun 2014 | B2 |
8747442 | Orbay et al. | Jun 2014 | B2 |
8764751 | Orbay et al. | Jul 2014 | B2 |
8764808 | Gonzalez-Hernandez | Jul 2014 | B2 |
8777998 | Daniels et al. | Jul 2014 | B2 |
8790376 | Fritzinger et al. | Jul 2014 | B2 |
8790377 | Ralph et al. | Jul 2014 | B2 |
8808333 | Kuster et al. | Aug 2014 | B2 |
8808334 | Strnad et al. | Aug 2014 | B2 |
8834532 | Velikov et al. | Sep 2014 | B2 |
8834537 | Castanada et al. | Sep 2014 | B2 |
8852246 | Hansson | Oct 2014 | B2 |
8852249 | Ahrens et al. | Oct 2014 | B2 |
8864802 | Schwager et al. | Oct 2014 | B2 |
8870931 | Dahners et al. | Oct 2014 | B2 |
8888825 | Batsch et al. | Nov 2014 | B2 |
8906076 | Mocanu et al. | Dec 2014 | B2 |
8911482 | Lee et al. | Dec 2014 | B2 |
8926675 | Leung et al. | Jan 2015 | B2 |
8940026 | Hilse et al. | Jan 2015 | B2 |
8940028 | Austin et al. | Jan 2015 | B2 |
8940029 | Leung et al. | Jan 2015 | B2 |
8951291 | Impellizzeri | Feb 2015 | B2 |
8968368 | Tepic | Mar 2015 | B2 |
9011457 | Grady, Jr. et al. | Apr 2015 | B2 |
9023052 | Lietz et al. | May 2015 | B2 |
9050151 | Schilter | Jun 2015 | B2 |
9072555 | Michel | Jul 2015 | B2 |
9072557 | Fierlbeck et al. | Jul 2015 | B2 |
9107678 | Murner et al. | Aug 2015 | B2 |
9107711 | Hainard | Aug 2015 | B2 |
9107713 | Horan et al. | Aug 2015 | B2 |
9107718 | Isch | Aug 2015 | B2 |
9113970 | Lewis et al. | Aug 2015 | B2 |
9149310 | Fritzinger et al. | Oct 2015 | B2 |
9161791 | Frigg | Oct 2015 | B2 |
9161795 | Chasbrummel et al. | Oct 2015 | B2 |
9168075 | Dell'Oca | Oct 2015 | B2 |
9179950 | Zajac et al. | Nov 2015 | B2 |
9179956 | Cerynik et al. | Nov 2015 | B2 |
9180020 | Gause et al. | Nov 2015 | B2 |
9211151 | Weaver et al. | Dec 2015 | B2 |
9259217 | Fritzinger et al. | Feb 2016 | B2 |
9259255 | Lewis et al. | Feb 2016 | B2 |
9271769 | Batsch et al. | Mar 2016 | B2 |
9283010 | Medoff et al. | Mar 2016 | B2 |
9295506 | Raven, III et al. | Mar 2016 | B2 |
9314284 | Chan et al. | Apr 2016 | B2 |
9320554 | Greenberg et al. | Apr 2016 | B2 |
9322562 | Takayama et al. | Apr 2016 | B2 |
9370388 | Globerman et al. | Jun 2016 | B2 |
D765851 | Early et al. | Sep 2016 | S |
9433407 | Fritzinger et al. | Sep 2016 | B2 |
9433452 | Weiner et al. | Sep 2016 | B2 |
9468479 | Marotta et al. | Oct 2016 | B2 |
9480512 | Orbay | Nov 2016 | B2 |
9486262 | Andermahr et al. | Nov 2016 | B2 |
9492213 | Orbay | Nov 2016 | B2 |
9510878 | Nanavati et al. | Dec 2016 | B2 |
9510880 | Terrill et al. | Dec 2016 | B2 |
9526543 | Castaneda et al. | Dec 2016 | B2 |
9545277 | Wolf et al. | Jan 2017 | B2 |
9549819 | Bravo et al. | Jan 2017 | B1 |
9566097 | Fierlbeck et al. | Feb 2017 | B2 |
9579133 | Guthlein | Feb 2017 | B2 |
9622799 | Orbay et al. | Apr 2017 | B2 |
9636157 | Medoff | May 2017 | B2 |
9649141 | Raven, III et al. | May 2017 | B2 |
9668794 | Kuster et al. | Jun 2017 | B2 |
9801670 | Hashmi et al. | Oct 2017 | B2 |
9814504 | Ducharme et al. | Nov 2017 | B2 |
10022135 | O'Reilly et al. | Jul 2018 | B2 |
10507048 | Overes et al. | Dec 2019 | B2 |
10905477 | Lueth et al. | Feb 2021 | B2 |
20020029041 | Hover et al. | Mar 2002 | A1 |
20020045901 | Wagner et al. | Apr 2002 | A1 |
20030074078 | Doubler et al. | Apr 2003 | A1 |
20040097937 | Pike et al. | May 2004 | A1 |
20050107796 | Gerlach et al. | May 2005 | A1 |
20050131413 | O'Driscoll et al. | Jun 2005 | A1 |
20050187551 | Orbay et al. | Aug 2005 | A1 |
20060030859 | Gotfried | Feb 2006 | A1 |
20060064106 | Fernandez | Mar 2006 | A1 |
20060149265 | James et al. | Jul 2006 | A1 |
20060200160 | Border et al. | Sep 2006 | A1 |
20060241607 | Myerson et al. | Oct 2006 | A1 |
20070173840 | Huebner | Jul 2007 | A1 |
20070270849 | Orbay et al. | Nov 2007 | A1 |
20070288022 | Lutz | Dec 2007 | A1 |
20080021477 | Strnad et al. | Jan 2008 | A1 |
20080234749 | Forstein | Sep 2008 | A1 |
20080275510 | Schonhardt et al. | Nov 2008 | A1 |
20080281331 | Fritzinger et al. | Nov 2008 | A1 |
20090024172 | Pizzicara | Jan 2009 | A1 |
20090024173 | Reis, Jr. | Jan 2009 | A1 |
20090118773 | James et al. | May 2009 | A1 |
20090198285 | Raven, III | Aug 2009 | A1 |
20090200160 | Abe et al. | Aug 2009 | A1 |
20090228010 | Gonzalez-Hernandez et al. | Sep 2009 | A1 |
20090228047 | Derouet et al. | Sep 2009 | A1 |
20090248084 | Hintermann | Oct 2009 | A1 |
20090281543 | Orbay et al. | Nov 2009 | A1 |
20090299369 | Orbay et al. | Dec 2009 | A1 |
20090312760 | Forstein et al. | Dec 2009 | A1 |
20090318926 | Christie | Dec 2009 | A1 |
20100057086 | Price et al. | Mar 2010 | A1 |
20100063503 | Dell'Oca | Mar 2010 | A1 |
20100114097 | Siravo et al. | May 2010 | A1 |
20100121326 | Woll et al. | May 2010 | A1 |
20100274247 | Grady, Jr. et al. | Oct 2010 | A1 |
20110054474 | Metzinger et al. | Mar 2011 | A1 |
20110054550 | Metzinger et al. | Mar 2011 | A1 |
20110077693 | Yu | Mar 2011 | A1 |
20110106086 | Laird | May 2011 | A1 |
20110218580 | Schwager et al. | Sep 2011 | A1 |
20110282398 | Overes | Nov 2011 | A1 |
20120010667 | Eglseder | Jan 2012 | A1 |
20120059424 | Epperly et al. | Mar 2012 | A1 |
20120203227 | Martin | Aug 2012 | A1 |
20120232599 | Schoenly et al. | Sep 2012 | A1 |
20120323284 | Baker et al. | Dec 2012 | A1 |
20130018426 | Tsai et al. | Jan 2013 | A1 |
20130046347 | Cheng et al. | Feb 2013 | A1 |
20130060291 | Petersheim | Mar 2013 | A1 |
20130123841 | Lyon | May 2013 | A1 |
20130138156 | Derouet | May 2013 | A1 |
20130150902 | Leite | Jun 2013 | A1 |
20130165981 | Clasbrummet et al. | Jun 2013 | A1 |
20130211463 | Mizuno et al. | Aug 2013 | A1 |
20130289630 | Fritzinger | Oct 2013 | A1 |
20130317502 | Overes | Nov 2013 | A1 |
20140005728 | Koay et al. | Jan 2014 | A1 |
20140018862 | Koay et al. | Jan 2014 | A1 |
20140031879 | Sixto, Jr. et al. | Jan 2014 | A1 |
20140066998 | Martin | Mar 2014 | A1 |
20140094856 | Sinha | Apr 2014 | A1 |
20140121710 | Weaver et al. | May 2014 | A1 |
20140180345 | Chan et al. | Jun 2014 | A1 |
20140214045 | Felder et al. | Jul 2014 | A1 |
20140277178 | O'Kane et al. | Sep 2014 | A1 |
20140277181 | Garlock | Sep 2014 | A1 |
20140316473 | Pfeffer et al. | Oct 2014 | A1 |
20140330320 | Wolter | Nov 2014 | A1 |
20140378975 | Castaneda et al. | Dec 2014 | A1 |
20150038967 | Khong | Feb 2015 | A1 |
20150038968 | Vega et al. | Feb 2015 | A1 |
20150051650 | Verstreken et al. | Feb 2015 | A1 |
20150051651 | Terrill et al. | Feb 2015 | A1 |
20150073486 | Marotta et al. | Mar 2015 | A1 |
20150105829 | Laird | Apr 2015 | A1 |
20150112355 | Dahners et al. | Apr 2015 | A1 |
20150134011 | Medoff | May 2015 | A1 |
20150142065 | Schonhardt et al. | May 2015 | A1 |
20150190185 | Koay et al. | Jul 2015 | A1 |
20150209091 | Sixto, Jr. et al. | Jul 2015 | A1 |
20150216571 | Impellizzeri | Aug 2015 | A1 |
20150223852 | Lietz et al. | Aug 2015 | A1 |
20150272638 | Langford | Oct 2015 | A1 |
20150282851 | Michel | Oct 2015 | A1 |
20150305791 | Purohit | Oct 2015 | A1 |
20150313653 | Ponce et al. | Nov 2015 | A1 |
20150313654 | Horan et al. | Nov 2015 | A1 |
20150327898 | Martin | Nov 2015 | A1 |
20150351816 | Lewis et al. | Dec 2015 | A1 |
20150374421 | Rocci et al. | Dec 2015 | A1 |
20160022336 | Bateman | Jan 2016 | A1 |
20160030035 | Zajac et al. | Feb 2016 | A1 |
20160045237 | Cerynik et al. | Feb 2016 | A1 |
20160045238 | Bohay et al. | Feb 2016 | A1 |
20160074081 | Weaver et al. | Mar 2016 | A1 |
20160089189 | Buscaglia et al. | Mar 2016 | A1 |
20160166297 | Mighell et al. | Jun 2016 | A1 |
20160166298 | Mighell et al. | Jun 2016 | A1 |
20160183990 | Koizumi et al. | Jun 2016 | A1 |
20160262814 | Wainscott | Sep 2016 | A1 |
20160278828 | Ragghianti | Sep 2016 | A1 |
20160310183 | Shah et al. | Oct 2016 | A1 |
20160310185 | Sixto et al. | Oct 2016 | A1 |
20160324552 | Baker et al. | Nov 2016 | A1 |
20160354122 | Montello et al. | Dec 2016 | A1 |
20170035478 | Andermahr et al. | Feb 2017 | A1 |
20170042592 | Kim | Feb 2017 | A1 |
20170042596 | Mighell et al. | Feb 2017 | A9 |
20170049493 | Gauneau et al. | Feb 2017 | A1 |
20170065312 | Lauf et al. | Mar 2017 | A1 |
20170105775 | Ricker et al. | Apr 2017 | A1 |
20170215931 | Cremer et al. | Aug 2017 | A1 |
20180078292 | Hedgeland et al. | Mar 2018 | A1 |
20180078294 | Hedgeland et al. | Mar 2018 | A1 |
20180250040 | Menci | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
201524132 | Jul 2010 | CN |
201987653 | Sep 2011 | CN |
202313691 | Jul 2012 | CN |
202821574 | Mar 2013 | CN |
202821575 | Mar 2013 | CN |
203506858 | Apr 2014 | CN |
203815563 | Sep 2014 | CN |
105982727 | Oct 2016 | CN |
4445692 | May 1996 | DE |
202006005629 | Jun 2006 | DE |
0321170 | Jun 1989 | EP |
0441577 | Aug 1991 | EP |
1759643 | Mar 2007 | EP |
2606836 | Jun 2013 | EP |
3636175 | Jul 2020 | EP |
3747375 | Dec 2020 | EP |
2846870 | May 2004 | FR |
2928259 | Sep 2009 | FR |
1996-505550 | Jun 1996 | JP |
H08505550 | Jun 1996 | JP |
200150765 | Jun 2001 | JP |
2003210478 | Jul 2003 | JP |
2008514296 | May 2008 | JP |
2009-112594 | May 2009 | JP |
2009-534106 | Sep 2009 | JP |
2009-537106 | Sep 2009 | JP |
2011-500215 | Jan 2011 | JP |
2011-206125 | Oct 2011 | JP |
2011206125 | Oct 2011 | JP |
2012147948 | Aug 2012 | JP |
2013-502992 | Jan 2013 | JP |
2013502992 | Jan 2013 | JP |
2016-504961 | Feb 2016 | JP |
2017-515554 | Jun 2017 | JP |
2018-149297 | Sep 2018 | JP |
2018149273 | Sep 2018 | JP |
2020-127742 | Aug 2020 | JP |
2021-000440 | Jan 2021 | JP |
201316942 | May 2013 | TW |
9415556 | Jul 1994 | WO |
2006091625 | Aug 2006 | WO |
2010053628 | May 2010 | WO |
2012103335 | Aug 2012 | WO |
2012103354 | Aug 2012 | WO |
2013092402 | Jun 2013 | WO |
2016079504 | May 2016 | WO |
20161511611 | Sep 2016 | WO |
2018091515 | May 2018 | WO |
Number | Date | Country | |
---|---|---|---|
20220079647 A1 | Mar 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16580174 | Sep 2019 | US |
Child | 17534555 | US | |
Parent | 15636806 | Jun 2017 | US |
Child | 16580174 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15272850 | Sep 2016 | US |
Child | 15636806 | US |